Bystolic Related Published Studies
Well-designed clinical trials related to Bystolic (Nebivolol)
beta-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial. [2011.08]
Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication. [2011.07]
Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial. [2011.06]
Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. [2011.06]
The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension. [2011.05]
Reversal of subclinical left ventricular dysfunction by antihypertensive treatment: a prospective trial of nebivolol against metoprolol. [2011.04]
Effects of Beta-Blockade on Exercise Performance at High Altitude: A Randomized, Placebo-Controlled Trial Comparing the Efficacy of Nebivolol versus Carvedilol in Healthy Subjects. [2011.03.11]
beta-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. [2011.02]
Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial. [2010.12]
Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA. [2010.08]
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]). [2010.07.01]
Nebivolol efficacy and safety in patients with stage I-II hypertension. [2010.04]
Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. [2010.03]
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. [2010.02]
Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension. [2010.01]
Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: a pilot study. [2010]
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). [2009.06.09]
The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X. [2009.05]
Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension. [2009.05]
Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. [2009.04]
A comparison of atenolol and nebivolol in isolated systolic hypertension. [2008.02]
Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment? [2008.01]
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus. [2007.12]
The efficacy and tolerability of nebivolol in hypertensive African American patients. [2007.11]
A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension. [2007.09]
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. [2007.07]
Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report. [2007.04]
Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. [2007.04]
Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol. [2007.03.20]
Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure. [2007.02]
Nebivolol: a third-generation beta-adrenergic blocker. [2006.07]
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. [2006.07]
Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients. [2006.03]
Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. [2006.03]
Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. [2006]
Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. [2006]
Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study. [2005.11]
Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. [2005.08]
Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study. [2005.06]
Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study. [2005.05]
Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. [2005.03]
Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan. [2005.02]
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). [2005.02]
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial. [2003.12]
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. [2003.10]
Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. [2003.08.01]
The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study. [2003.06]
Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS). [2003.05]
Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study. [2003.05]
[Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure] [2003.01.15]
Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study. [2002.12]
Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. [2002.09]
Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly. [2002]
[Nebivolol (nebilet) a beta blocker of the third generation--also for patients with obstructive lung diseases?] [2001.10]
Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients. [2001.08]
Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. [2001.07.31]
Nebivolol decreases systemic oxidative stress in healthy volunteers. [2000.10]
Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension. [1999.05]
Nebivolol versus enalapril in essential hypertension: a long-term double-blind comparative trial. [1999.01]
Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure. [1998.09]
Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial. [1998.07]
Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial. [1998.02]
Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial. [1997.12]
Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial. [1997.12]
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. [1997.11]
A dose-response trial of nebivolol in essential hypertension. [1997.02]
Well-designed clinical trials possibly related to Bystolic (Nebivolol)
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study. [2011.06]
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. [2011.02]
The role of carvedilol in the management of portal hypertension. [2010.08]
Effects of beta-blockers on glucose and lipid metabolism. [2010.03]
Treatment of heart failure with preserved systolic function. [2008.05]
Pediatric Heart Failure Therapy with beta-Adrenoceptor Antagonists. [2008]
A comparison of the beta1-selectivity of three beta1-selective beta-blockers. [2003.06]
Different effect of antihypertensive drugs on conduit artery endothelial function. [2003.06]
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. [1997.06]
Other research related to Bystolic (Nebivolol)
Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress
in essential hypertension. [2012]
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. [2011.12.06]
Nebivolol for the treatment of heart failure. [2011.12]
Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: The NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study. [2011.11.09]
Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats. [2011.11]
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. [2011.10.22]
[Comparative effects of nebivolol and valsartan on atrial electromechanical coupling in newly diagnosed stage 1 hypertensive patients]. [2011.10]
Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats. [2011.10]
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients. [2011.09]
Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials. [2011.09]
Improvement of left ventricular diastolic function induced by beta-blockade: a comparison between nebivolol and metoprolol. [2011.08]
Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension. [2011.07]
Lack of evidence that nebivolol is a beta-adrenoceptor agonist. [2011.03.01]
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade. [2011.02.01]
Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. [2011.02]
The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats. [2011.01]
Comparative long term effects of nebivolol and carvedilol in hypertensive heart
failure patients. [2011]
Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure. [2010.12.03]
Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study. [2010.09]
The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol. [2010.07]
The role of vasodilating beta-blockers in patients with complicated hypertension: focus on nebivolol. [2010.07]
Nebivolol/hydrochlorothiazide (HCTZ) combination in patients with essential hypertension: a pooled analysis from five non-interventional studies with a focus on diabetic and elderly patients. [2010.05]
Nebivolol in chronic heart failure: current evidence and future perspectives. [2010.04]
Nebivolol prevents remodeling in a rat myocardial infarction model: an echocardiographic study. [2010.02]
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. [2010]
Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol. [2010]
|
